ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
markhughes
|
1.0K |
392K |
11 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
392K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
markhughes
|
1.3K |
546K |
0 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.3K
|
546K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
markhughes
|
1.3K |
546K |
10 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
546K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
markhughes
|
1.3K |
546K |
3 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
546K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
markhughes
|
36 |
17K |
7 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
36
|
17K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
markhughes
|
1.3K |
546K |
6 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
546K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
markhughes
|
1.3K |
546K |
6 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
546K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
markhughes
|
1.3K |
546K |
6 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
546K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
markhughes
|
1.3K |
546K |
23 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
546K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Time to buy MSB and ride the wave ?
|
|
markhughes
|
144 |
53K |
3 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
144
|
53K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
markhughes
|
3.4K |
1.1M |
0 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
markhughes
|
9.5K |
2.8M |
3 |
15/07/23 |
15/07/23 |
ASX - By Stock
|
9.5K
|
2.8M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
markhughes
|
3.4K |
1.1M |
11 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
markhughes
|
3.4K |
1.1M |
8 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
markhughes
|
3.4K |
1.1M |
0 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
markhughes
|
3.4K |
1.1M |
5 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
markhughes
|
9.5K |
2.8M |
2 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
9.5K
|
2.8M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Reports Q3 Financial Results and Operational Highlights
|
|
markhughes
|
362 |
112K |
2 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
362
|
112K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Reports Q3 Financial Results and Operational Highlights
|
|
markhughes
|
362 |
112K |
4 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
362
|
112K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
markhughes
|
55 |
21K |
16 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
55
|
21K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Reports Q3 Financial Results and Operational Highlights
|
|
markhughes
|
362 |
112K |
1 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
362
|
112K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
markhughes
|
55 |
21K |
9 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
55
|
21K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
markhughes
|
55 |
21K |
26 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
55
|
21K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
markhughes
|
274 |
120K |
9 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
274
|
120K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
William Blair initiated coverage of MESO
|
|
markhughes
|
59 |
16K |
27 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
59
|
16K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
markhughes
|
893 |
275K |
11 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
893
|
275K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Second Quarter Results Presentation
|
|
markhughes
|
117 |
29K |
6 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
117
|
29K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Second Quarter Results Presentation
|
|
markhughes
|
117 |
29K |
10 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
117
|
29K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
markhughes
|
914 |
286K |
16 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
914
|
286K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
markhughes
|
914 |
286K |
11 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
914
|
286K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
What could be the hold up?
|
|
markhughes
|
28 |
8.7K |
7 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
28
|
8.7K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Highlights
|
|
markhughes
|
194 |
67K |
8 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
194
|
67K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
markhughes
|
256 |
108K |
24 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
256
|
108K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
markhughes
|
129 |
44K |
15 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
129
|
44K
|
15
|
|
ASX - By Stock
|
RRL |
Re:
Ann: FY22 Guidance Update
|
|
markhughes
|
106 |
60K |
8 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
106
|
60K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
markhughes
|
408 |
123K |
4 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
408
|
123K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
markhughes
|
408 |
123K |
19 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
408
|
123K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
markhughes
|
408 |
123K |
3 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
408
|
123K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
markhughes
|
408 |
123K |
2 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
408
|
123K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
markhughes
|
115 |
45K |
6 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
115
|
45K
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
markhughes
|
10K |
3.0M |
5 |
02/12/21 |
02/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Q1 Financial Results and Operational Highlights
|
|
markhughes
|
124 |
38K |
4 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
124
|
38K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Can Mesoblast continue in it's current form
|
|
markhughes
|
18 |
4.8K |
17 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
18
|
4.8K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2021 Full Year Financial Results Webcast
|
|
markhughes
|
195 |
64K |
0 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
195
|
64K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Financial Results Presentation
|
|
markhughes
|
77 |
22K |
5 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
77
|
22K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
markhughes
|
10K |
3.0M |
2 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
markhughes
|
10K |
3.0M |
11 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MSB website indicates Novartis agreement as conditions met.
|
|
markhughes
|
158 |
46K |
0 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
158
|
46K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
markhughes
|
17K |
6.6M |
1 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
17K
|
6.6M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
markhughes
|
10K |
3.0M |
5 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|